Literature DB >> 10728375

Metabolic aspects of programmed cell survival and cell death in the heart.

C Depre1, H Taegtmeyer.   

Abstract

Normal cardiac function requires a tight interaction between metabolism, contractile function and gene expression. The main perturbation challenging this equilibrium in vivo is ischemia, which alters energy flux through the control of key enzymes. The review highlights metabolic imprints and energetic aspects of programmed cell survival, programmed cell death, and of necrosis. When sustained and severe, ischemia leads to a total collapse of energy transfer, to the accumulation of metabolic endproducts, and to the development of myocardial necrosis. When moderate, ischemia results in a coordinated cellular response including enhanced anaerobic glucose metabolism, a modification of cardiac gene expression, and the development of specific mechanisms for programmed cell survival (preconditioning, stunning, hibernation). Repetitive stress results in a decrease of contractile function, a downregulation of gene expression and an impairment of energy transfer, which eventually cause the heart to fail. When the failing heart becomes energy-depleted, the programs of cell survival are no longer operational and programmed cell death ensues. To define the point of departure from programmed cell survival to cell death remains a major challenge.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728375     DOI: 10.1016/s0008-6363(99)00266-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  28 in total

Review 1.  Targeted metabolic imaging to improve the management of heart disease.

Authors:  Moritz Osterholt; Shiraj Sen; Vasken Dilsizian; Heinrich Taegtmeyer
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

2.  Metabolic adaptation to myocardial ischemia: the role of fatty acid imaging.

Authors:  Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

3.  Hibernating myocardium: Programmed cell survival or programmed cell death?

Authors:  Marcel Borgers
Journal:  Exp Clin Cardiol       Date:  2002

Review 4.  Tracing cardiac metabolism in vivo: one substrate at a time.

Authors:  Heinrich Taegtmeyer
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

5.  Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction.

Authors:  Massimiliano Gnecchi; Huamei He; Luis G Melo; Nicolas Noiseaux; Fulvio Morello; Rudolf A de Boer; Lunan Zhang; Richard E Pratt; Victor J Dzau; Joanne S Ingwall
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

6.  Tissue-specific pyruvate dehydrogenase complex deficiency causes cardiac hypertrophy and sudden death of weaned male mice.

Authors:  Sukhdeep Sidhu; Ashish Gangasani; Lioubov G Korotchkina; Gen Suzuki; James A Fallavollita; John M Canty; Mulchand S Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-27       Impact factor: 4.733

7.  Glycogen metabolism in rat heart muscle cultures after hypoxia.

Authors:  Ayelet Vigoda; Liaman K Mamedova; Vladimir Shneyvays; Abram Katz; Asher Shainberg
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

Review 8.  Return to the fetal gene program protects the stressed heart: a strong hypothesis.

Authors:  Mitra Rajabi; Christos Kassiotis; Peter Razeghi; Heinrich Taegtmeyer
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 9.  Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.

Authors:  Caitlund Q Davidson; Christopher P Phenix; T C Tai; Neelam Khaper; Simon J Lees
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05

10.  Insulin resistance and risk of incident heart failure: Cardiovascular Health Study.

Authors:  Dipanjan Banerjee; Mary L Biggs; Laina Mercer; Kenneth Mukamal; Robert Kaplan; Joshua Barzilay; Lewis Kuller; Jorge R Kizer; Luc Djousse; Russell Tracy; Susan Zieman; Donald Lloyd-Jones; David Siscovick; Mercedes Carnethon
Journal:  Circ Heart Fail       Date:  2013-04-10       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.